A Case Report of Mania and Psychosis Five Months after Traumatic Brain Injury Successfully Treated Using Olanzapine

Cittolin-Santos, Giordano F.; Fredeen, Jesse C.; Cotes, Robert O.

doi:https://doi.org/10.1155/2017/7541307

Case Reports in Psychiatry

On this page

Abstract Introduction Case Presentation Discussion Conflicts of Interest References Copyright Related Articles

Case Report | Open Access

Volume 2017 | Article ID 7541307 | https://doi.org/10.1155/2017/7541307

A Case Report of Mania and Psychosis Five Months after Traumatic Brain Injury Successfully Treated Using Olanzapine

Giordano F. Cittolin-Santos,¹Jesse C. Fredeen,²and Robert O. Cotes²

Academic Editor: Toshiya Inada

Received27 Mar 2017

Accepted22 May 2017

Published12 Jun 2017

Abstract

Background. There are few published pharmacologic trials for the treatment of acute mania following traumatic brain injury (TBI). To our knowledge, we present the first case report of an individual being treated and stabilized with olanzapine monotherapy for this condition. Case Presentation. We describe the case of a 53-year-old African American male admitted to an inpatient psychiatric hospital with one month of behavioral changes including irritability, decreased need for sleep, hyperverbal speech, hypergraphia, and paranoia five months after TBI. Using Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria, he was diagnosed with bipolar disorder due to traumatic brain injury, with manic features. He was serially evaluated with clinical rating scales to measure symptom severity. The Young Mania Rating Scale (YMRS) score upon admission was 31, and the Clinician-Rated Dimensions of Psychosis Symptom Severity (CRDPSS) score was initially 9. After eight days of milieu treatment and gradual titration of olanzapine to 15 mg nightly, his symptoms completely abated, with YMRS and CRDPSS scores at zero on the day of discharge. Conclusion. Olanzapine was effective and well tolerated for the treatment of mania following TBI.

1. Introduction

Mania develops in 1.9–9% of individuals after experiencing traumatic brain injury (TBI) [1, 2]. Yet, there is a dearth of literature on pharmacologic treatment options for mania following TBI. The guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury, published in 2006, concluded there was insufficient evidence to support the development of standards or guidelines in the treatment of TBI related mania [3]. Four studies were included in the review, including three case series (each with two patients) and one case report. Treatments successful in treating mania included clonidine [4], thioridazine/amitriptyline [5], electroconvulsive therapy [5], lithium [6], and valproate [6]. In addition to the studies presented in the 2006 guidelines, successful trials have been published with carbamazepine/lithium [7], lithium/thioridazine [8], lithium monotherapy [9–11], valproate/olanzapine [12–14], valproate monotherapy [15], carbamazepine/chlorpromazine [16, 17], haloperidol [16], haloperidol/chlorpromazine [18], haloperidol/clonazepam [19], and quetiapine [20]. Here, we present the first case report of successful treatment with olanzapine monotherapy for mania after a traumatic brain injury.

2. Case Presentation

A 53-year-old African American male was brought by Emergency Medical Services (EMS) to the Emergency Room (ER) of an urban, public teaching hospital, due to threatening behavior, irritability, and an inability to care for himself. During the initial psychiatric consultation in the ER, the patient was hyperverbal with pressured speech and a tangential thought process. His mood was elevated, and his affect was labile with sudden and inappropriate bouts of tearfulness. He endorsed decreased need for sleep over the past few days and paranoid and persecutory delusions regarding strange noises around his apartment and his brother stealing money from his father. Per the EMS report, the patient was also emailing and texting neighbors paranoid and threatening messages, which resulted in multiple crisis hotline calls and the patient being brought to the hospital.

His past medical history was significant for a depressive episode treated successfully 25 years ago with sertraline and TBI five months prior to presentation. After the injury, he was followed by an outpatient neurologist for postconcussive syndrome. A brain MRI was ordered three months after TBI, which showed signs of mild white matter small vessel ischemic changes, but no other significant findings. The initial ER workup included a urinalysis, urine drug screen, complete metabolic panel, and thyroid function, all of which were unremarkable. A noncontrast CT scan of the brain was obtained and was unremarkable. He was admitted for inpatient psychiatric hospitalization. Using Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria [21], he was diagnosed with bipolar disorder due to traumatic brain injury, with manic features.

The patient was started on olanzapine 2.5 mg by mouth at bedtime upon admission. Manic features remained prominent, as he continued to demonstrate decreased need for sleep (three to five hours per night), pressured speech, irritability, emotional dysregulation, and labile affect. He often arose early in the morning and spent multiple hours writing questions for his treatment team. He refused valproate and lithium despite the team’s suggestions. Olanzapine was gradually titrated and reached 15 mg on hospital day (HD) 6. Aside from one instance of refusal on HD 5, he was adherent with olanzapine throughout the hospitalization. Olanzapine was well tolerated. He was evaluated with serial clinical rating scales which included the Young Mania Rating Scale (YMRS) and the Clinician-Rated Dimensions of Psychosis Symptom Severity (CRDPSS). On HD 1, the YMRS score was 31 and CRDSS was 9. On HD 6, the YMRS score decreased to 30 and CRDPSS decreased to 7. On HD 7, he displayed significant clinical improvement. He slept throughout the night and on interview no longer had pressured speech. His thought process was logical, linear, and goal-directed, and the psychotic symptoms had also fully abated. On HD 8, the YMRS and CRDPSS scores were 0. He was subsequently discharged from hospital with appropriate outpatient follow-up.

3. Discussion

Mania due to TBI is a challenging diagnosis to make with confidence, and this can make the limited research challenging to interpret. TBI may be an independent risk factor for the development of bipolar disorder [1, 22–24] and the DSM-5 does not report a definitive time course for which the diagnosis of TBI must take place and symptoms must emerge in order for the disorder to be characterized as mania due to TBI [21]. As in our case, the majority of individuals who ultimately develop bipolar disorder report a depressive episode first [25], but the later age of onset of manic symptoms and temporal relationship to TBI lends credence to the TBI’s primary role in the development of manic symptoms. In the case presented here, the patient exhibited a combination of manic and psychotic symptoms, but manic symptoms were predominant. The duration of the manic episode (likely around 2 months) was within range of other manic episodes reported after TBI. In study of six patients following head injury who experienced mania, the duration of the episode was 2 months, and the mean estimated duration of elevated mood was 5.7 months [2].

Olanzapine is a second-generation antipsychotic medication effective for the treatment of acute bipolar mania [26] and recommended for acute mania by various guidelines across the world [27–29]. However, few pharmacologic (and no randomized) trials exist for the treatment of mania following TBI. Olanzapine has been used for acute mania following TBI in several reported cases. Grenne et al. [30] described a case of a 13-year-old boy treated with olanzapine 10 mg daily and zonisamide who had improvement of auditory hallucinations but continued mania and delusions. A 60-year-old man was treated with an unspecified dose of olanzapine and 2500 mg of valproate five months after a head injury [12]. A 42-year-old man was treated with olanzapine 15 mg daily and valproate 1000 mg daily for mania emerging three years after a head trauma [13]. A 69-year-old man eighteen months after TBI was treated with 7.5 mg of olanzapine and 250 mg of valproate three times daily [14]. In each of these cases, olanzapine was combined with another medication, and of note, valproate alone has been effective in treating mania secondary to TBI [15], making it challenging to know if the patient improved related to olanzapine or valproate. Furthermore, olanzapine monotherapy has been shown to be effective in treating psychotic symptoms following traumatic brain injury in two case reports [31, 32]. In the case presented here, the patient was not agreeable to other pharmacologic treatments despite being offered lithium and valproate augmentation. In a 2014 review article, Jorge and Arciniegas recommended valproate or quetiapine as first-line therapies for bipolar disorder due to TBI [33]. We conclude that olanzapine could also be considered for this population, as it was effective and well tolerated in this case.

Conflicts of Interest

Dr. Robert O. Cotes has accepted research funding, consultation fees, and/or honoraria from Alkermes, Janssen, and Otsuka Pharmaceuticals. Drs. Giordano F. Cittolin-Santos and Jesse C. Fredeen have nothing to disclose.

References

J. M. Silver, R. Kramer, S. Greenwald, and M. Weissman, “The association between head injuries and psychiatric disorders: Findings from the New Haven NIMH Epidemiologic Catchment Area Study,” Brain Injury, vol. 15, no. 11, pp. 935–945, 2001.
View at: Publisher Site | Google Scholar
R. E. Jorge, R. G. Robinson, S. E. Starkstein, S. V. Arndt, A. W. Forrester, and F. H. Geisler, “Secondary mania following traumatic brain injury,” American Journal of Psychiatry, vol. 150, no. 6, pp. 916–921, 1993.
View at: Google Scholar
D. L. Warden, B. Gordon, T. W. McAllister et al., “Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury,” Journal of Neurotrauma, vol. 23, no. 10, pp. 1468–1501, 2006.
View at: Publisher Site | Google Scholar
S. Bakchine, L. Lacomblez, N. Benoit, D. Parisot, F. Chain, and F. Lhermitte, “Manic-like state after bilateral orbitofrontal and right temporoparietal injury: Efficacy of clonidine,” Neurology, vol. 39, no. 6, pp. 777–781, 1989.
View at: Publisher Site | Google Scholar
A. F. Clark and K. Davison, “Mania following head injury. A report of two cases and a review of the literature,” British Journal of Psychiatry, vol. 150, pp. 841–844, 1987.
View at: Google Scholar
M. S. Hale and J. O. Donaldson, “Lithium carbonate in the treatment of organic brain syndrome,” Journal of Nervous and Mental Disease, vol. 170, no. 6, pp. 362–365, 1982.
View at: Google Scholar
J. T. Stewart and R. H. Hemsath, “Bipolar illness following traumatic brain injury: treatment with lithium and carbamazepine,” Journal of Clinical Psychiatry, vol. 49, no. 2, pp. 74-75, 1988.
View at: Google Scholar
J. S. Bamrah and J. Johnson, “Bipolar affective disorder following head injury,” British Journal of Psychiatry, vol. 158, pp. 117–119, 1991.
View at: Google Scholar
L. N. Yatham, J. C. Benbow, and A. M. Jeffers, “Mania following head injury,” Acta Psychiatrica Scandinavica, vol. 77, no. 3, pp. 359-360, 1988.
View at: Publisher Site | Google Scholar
T. Murai and S. Fujimoto, “Rapid cycling bipolar disorder after left temporal polar damage,” Brain Injury, vol. 17, no. 4, pp. 355–358, 2003.
View at: Publisher Site | Google Scholar
P. Joshi, J. A. Capozzoli, and J. T. Coyle, “Effective management with lithium of a persistent, post-traumatic hypomania in a 10-year-old child,” Journal of Developmental and Behavioral Pediatrics, vol. 6, no. 6, pp. 352–354, 1985.
View at: Google Scholar
K. Masodkar and S. Khan, “Traumatic brain injury–induced mania,” Primary Care Companion to the Journal of Clinical Psychiatry, vol. 17, no. 2, 2015.
View at: Publisher Site | Google Scholar
S. B. Zincir, F. Izci, and G. Acar, “Mania secondary to traumatic brain injury: A case report,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 26, no. 2, p. E31, 2014.
View at: Publisher Site | Google Scholar
T. W. Heinrich and J. T. Junig, “Recurrent mania associated with repeated brain injury,” General Hospital Psychiatry, vol. 26, no. 6, pp. 490–492, 2004.
View at: Publisher Site | Google Scholar
A. Monji, I. Yoshida, H. Koga, K.-I. Tashiro, and N. Tashiro, “Brain injury-induced rapid-cycling affective disorder successfully treated with valproate [1],” Psychosomatics, vol. 40, no. 5, pp. 448-449, 1999.
View at: Publisher Site | Google Scholar
S. H. Nizamie, A. Nizamie, M. Borde, and S. Sharma, “Mania following head injury: Case reports and neuropsychological findings,” Acta Psychiatrica Scandinavica, vol. 77, no. 6, pp. 637–639, 1988.
View at: Publisher Site | Google Scholar
K. Sayal, T. Ford, and R. Pipe, “Case study: bipolar disorder after head injury,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 39, no. 4, pp. 525–528, 2000.
View at: Google Scholar
P. Bracken, “Mania following head injury,” British Journal of Psychiatry, vol. 150, pp. 690–692, 1987.
View at: Google Scholar
B. Mustafa, O. Evrim, and A. Sari, “Secondary mania following traumatic brain injury,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 17, no. 1, pp. 122–124, 2005.
View at: Google Scholar
T. J. Oster, C. A. Anderson, C. M. Filley, H. S. Wortzel, and D. B. Arciniegas, “Quetiapine for mania due to traumatic brain injury,” CNS Spectrums, vol. 12, no. 10, pp. 764–769, 2007.
View at: Google Scholar
Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Arlington, VA, USA, 5th edition, 2013.
D. Malaspina, R. R. Goetz, J. H. Friedman et al., “Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees,” American Journal of Psychiatry, vol. 158, no. 3, pp. 440–446, 2001.
View at: Publisher Site | Google Scholar
P. B. Mortensen, O. Mors, M. Frydenberg, and H. Ewald, “Head injury as a risk factor for bipolar affective disorder,” Journal of Affective Disorders, vol. 76, no. 1-3, pp. 79–83, 2003.
View at: Publisher Site | Google Scholar
S. Orlovska, M. S. Pedersen, M. E. Benros, P. B. Mortensen Dr., E. Agerbo Dr., and M. Nordentoft Dr., “Head injury as risk factor for psychiatric disorders: A nationwide register-based follow-up study of 113,906 persons with head injury,” American Journal of Psychiatry, vol. 171, no. 4, pp. 463–469, 2014.
View at: Publisher Site | Google Scholar
D. J. Kupfer, E. Frank, V. J. Grochocinski, P. A. Cluss, P. R. Houck, and D. A. Stapf, “Demographic and clinical characteristics of individuals in a bipolar disorder case registry,” Journal of Clinical Psychiatry, vol. 63, no. 2, pp. 120–125, 2002.
View at: Google Scholar
A. Cipriani, C. Barbui, G. Salanti et al., “Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis,” The Lancet, vol. 378, no. 9799, pp. 1306–1315, 2011.
View at: Publisher Site | Google Scholar
T. Suppes, E. B. Dennehy, R. M. Hirschfeld et al., “The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder,” Journal of Clinical Psychiatry, vol. 66, no. 7, pp. 870–886, 2005.
View at: Google Scholar
S. N. Ghaemi, M. Bauer, F. Cassidy et al., “Diagnostic guidelines for bipolar disorder: A summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report,” Bipolar Disorders, vol. 10, no. 1, pp. 117–128, 2008.
View at: Publisher Site | Google Scholar
H. Grunze, S. Kasper, G. Goodwin et al., “The World Federation of Socleties of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: Treatment of mania,” World Journal of Biological Psychiatry, vol. 4, no. 1, pp. 5–13, 2003.
View at: Publisher Site | Google Scholar
M. B. Greene, J. Frank, S. Kremer, C. Bursztejn, and J. Foucher, “Manic psychosis and auditory hallucinations following traumatic brain injury in a 13-year-old boy,” Journal of Clinical Psychiatry, vol. 71, no. 4, pp. 506-507, 2010.
View at: Publisher Site | Google Scholar
D. F. Guerreiro, R. Navarro, M. Silva, M. Carvalho, and C. Gois, “Psychosis secondary to traumatic brain injury,” Brain Injury, vol. 23, no. 4, pp. 358–361, 2009.
View at: Publisher Site | Google Scholar
B. D. M. Viana, H. A. C. Prais, R. Nicolato, and P. Caramelli, “Posttraumatic brain injury psychosis successfully treated with olanzapine,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 34, no. 1, pp. 233–235, 2010.
View at: Publisher Site | Google Scholar
R. E. Jorge and D. B. Arciniegas, “Mood disorders after TBI,” Psychiatric Clinics of North America, vol. 37, no. 1, pp. 13–29, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2017 Giordano F. Cittolin-Santos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

7560

Downloads

1172

Citations